NO791643L - Cancer-tilknyttet protein og fremgangsmaate for fremstilling derav - Google Patents
Cancer-tilknyttet protein og fremgangsmaate for fremstilling deravInfo
- Publication number
- NO791643L NO791643L NO791643A NO791643A NO791643L NO 791643 L NO791643 L NO 791643L NO 791643 A NO791643 A NO 791643A NO 791643 A NO791643 A NO 791643A NO 791643 L NO791643 L NO 791643L
- Authority
- NO
- Norway
- Prior art keywords
- iac
- cadet
- antibodies
- protein
- antibody
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK216378 | 1978-05-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO791643L true NO791643L (no) | 1979-11-20 |
Family
ID=8110498
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO791643A NO791643L (no) | 1978-05-17 | 1979-05-16 | Cancer-tilknyttet protein og fremgangsmaate for fremstilling derav |
Country Status (15)
| Country | Link |
|---|---|
| JP (1) | JPS5516291A (fr) |
| AU (1) | AU521404B2 (fr) |
| BE (1) | BE876301A (fr) |
| DE (1) | DE2919833A1 (fr) |
| ES (1) | ES480624A1 (fr) |
| FI (1) | FI791551A7 (fr) |
| FR (1) | FR2426055A1 (fr) |
| GB (1) | GB2021593A (fr) |
| IT (1) | IT7968046A0 (fr) |
| LU (1) | LU81273A1 (fr) |
| NL (1) | NL7903854A (fr) |
| NO (1) | NO791643L (fr) |
| NZ (1) | NZ190470A (fr) |
| PT (1) | PT69617A (fr) |
| SE (1) | SE7904276L (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2121417A (en) * | 1982-02-22 | 1983-12-21 | Carlton Med Prod | Antigens and antibodies useful in the detection of cancer |
| AU569467B2 (en) * | 1982-04-07 | 1988-02-04 | Baylor College Of Medicine | Immunoglobulin based cancer treating pharmaceutical compositions |
-
1979
- 1979-05-15 SE SE7904276A patent/SE7904276L/ not_active Application Discontinuation
- 1979-05-15 FI FI791551A patent/FI791551A7/fi not_active Application Discontinuation
- 1979-05-16 LU LU81273A patent/LU81273A1/fr unknown
- 1979-05-16 NO NO791643A patent/NO791643L/no unknown
- 1979-05-16 NL NL7903854A patent/NL7903854A/xx not_active Application Discontinuation
- 1979-05-16 GB GB7917107A patent/GB2021593A/en not_active Withdrawn
- 1979-05-16 DE DE19792919833 patent/DE2919833A1/de not_active Withdrawn
- 1979-05-16 PT PT69617A patent/PT69617A/fr unknown
- 1979-05-16 BE BE6/46832A patent/BE876301A/fr unknown
- 1979-05-16 ES ES480624A patent/ES480624A1/es not_active Expired
- 1979-05-16 NZ NZ190470A patent/NZ190470A/xx unknown
- 1979-05-16 FR FR7912426A patent/FR2426055A1/fr not_active Withdrawn
- 1979-05-17 JP JP6213379A patent/JPS5516291A/ja active Pending
- 1979-05-17 IT IT7968046A patent/IT7968046A0/it unknown
- 1979-05-17 AU AU47172/79A patent/AU521404B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| ES480624A1 (es) | 1980-08-16 |
| FI791551A7 (fi) | 1981-01-01 |
| DE2919833A1 (de) | 1979-11-29 |
| IT7968046A0 (it) | 1979-05-17 |
| NL7903854A (nl) | 1979-11-20 |
| LU81273A1 (fr) | 1979-09-10 |
| SE7904276L (sv) | 1979-11-18 |
| AU4717279A (en) | 1979-11-22 |
| AU521404B2 (en) | 1982-04-01 |
| JPS5516291A (en) | 1980-02-04 |
| FR2426055A1 (fr) | 1979-12-14 |
| GB2021593A (en) | 1979-12-05 |
| BE876301A (fr) | 1979-11-16 |
| PT69617A (fr) | 1979-06-01 |
| NZ190470A (en) | 1982-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Muller-Eberhard et al. | Isolation and description of the fourth component of human complement | |
| Ballow et al. | Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them | |
| Dahl et al. | Glial fibrillary acidic protein from normal human brain. Purification and properties | |
| Clark et al. | Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythmatosus | |
| US3995018A (en) | Method of binding immunoglobulin employing a polypeptide from microorganisms | |
| Kennel et al. | Isolation and characterization of plasma membrane associated immunoglobulin from cultured human diploid lymphocytes | |
| JPS6218869B2 (fr) | ||
| Reisfeld et al. | Association of HL-A antigens and β 2-microglobulin at the cellular and molecular level | |
| Mannik et al. | Antibody-agarose immunoadsorbents: complete removal of classes of immunoglobulins from serum | |
| DK150810B (da) | Fremgangsmaade til bestemmelse af et eller flere antigener i en proeve ved hjaelp af antistof bundet til smaa partikler | |
| Dunne et al. | Schistosoma mansoni egg antigens: preparation of rabbit antisera with monospecific immunoprecipitating activity, and their use in antigen characterization | |
| Quinn et al. | Early pregnancy factor in liver regeneration after partial hepatectomy in rats: relationship with chaperonin 10 | |
| CA1265048A (fr) | Proteine caracteristique de l'arthtrite rheumatoide | |
| Olson et al. | Localization of phosphoprotein C23 in nucleoli by immunological methods | |
| US5030578A (en) | Process for the purification of C1-inhibitor | |
| CA1101847A (fr) | Traduction non-disponible | |
| Kriegler et al. | Phenotypic complementation of the SV40 tsA mutant defect in viral DNA synthesis following microinjection of SV40 T antigen | |
| Nielsen et al. | Cell-cell adhesion in the embryonic chick: partial purification of liver adhesion molecules from liver membranes | |
| NO791643L (no) | Cancer-tilknyttet protein og fremgangsmaate for fremstilling derav | |
| Marashi et al. | Purification and partial characterization of nucleolar antigen-1 of the Novikoff hepatoma | |
| Aasted | Purification and characterization of Aleutian disease virus | |
| WO2019128758A1 (fr) | Anticorps destiné à être utilisé dans la détection d'un dommage de stade précoce de la barrière hémato-encéphalique pendant un accident ischémique cérébral et application associée | |
| Lahav et al. | Biological activity of the cleavage product of human immunoglobulin G with cyanogen bromide | |
| Hughes et al. | The immunopurification of tetanus toxoid | |
| CA1086306A (fr) | Reactif pour epreuve d'immunofluorescence et procede de preparation |